FollowME Fabry Pathfinders real-world registry in Spain and Portugal: cardiac and renal outcomes with migalastat in patients with Fabry disease

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Professor Olga Azevedo

Hospital Guimaraes, Guimaraes (Portugal)

7 More presentations in this session

Presentation thumbnail

Cardiovascular prognostic determinants in anderson-fabry disease: insights from a multicenter cohort study

Doctor Y. Chen (Shanghai, CN)

Abstract Slides Video

Presentation thumbnail

Apical hypertrophic cardiomyopathy: could it be Fabry?

Doctor S. Findlay (Cambridge, GB)

Abstract Slides Video

Presentation thumbnail

Prevalence of pseudo-delta wave in Anderson-Fabry disease and challenges in differentiating from ventricular pre-excitation

Doctor S. Serratore (Catanzaro, IT)

Abstract Slides Video

Presentation thumbnail

Fabry disease screening in patients with idiopathic HCM or idiopathic LVH: preliminary data from the multicentric nationwide F-CHECK study

Doctor E. Martins (Porto, PT)

Abstract Slides Video

Presentation thumbnail

Role of myocardial inflammation in the progression of Fabry cardiomyopathy: a multicentre cardiac magnetic resonance study

Doctor M. Schiavo (Bologna, IT)

Abstract Slides Video

Access the full session

Session thumbnail

Fabry disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Cardiovascular prognostic determinants in anderson-fabry disease: insights from a multicenter cohort study

Congress Presentation

Safety and efficacy of migalastat in Fabry's disease treatment with cardiac impact : a systematic review and meta-analysis

Congress Presentation

Cardiovascular events in patients with Fabry disease: data froma multicentric nationwide study

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources